Literature DB >> 19136608

Adaptive response of the heart to long-term anemia induced by iron deficiency.

Yoshiro Naito1, Takeshi Tsujino, Mika Matsumoto, Tsuyoshi Sakoda, Mitsumasa Ohyanagi, Tohru Masuyama.   

Abstract

Anemia is common in patients with chronic heart failure and an independent predictor of poor prognosis. Chronic anemia leads to left ventricular (LV) hypertrophy and heart failure, but its molecular mechanisms remain largely unknown. We investigated the mechanisms, including the molecular signaling pathway, of cardiac remodeling induced by iron deficiency anemia (IDA). Weanling Sprague-Dawley rats were fed an iron-deficient diet for 20 wk to induce IDA, and the molecular mechanisms of cardiac remodeling were evaluated. The iron-deficient diet initially induced severe anemia, which resulted in LV hypertrophy and dilation with preserved systolic function associated with increased serum erythropoietin (Epo) concentration. Cardiac STAT3 phosphorylation and VEGF gene expression increased by 12 wk of IDA, causing angiogenesis in the heart. Thereafter, sustained IDA induced upregulation of cardiac hypoxia inducible factor-1alpha gene expression and maintained upregulation of cardiac VEGF gene expression and cardiac angiogenesis; however, sustained IDA promoted cardiac fibrosis and lung congestion, with decreased serum Epo concentration and cardiac STAT3 phosphorylation after 20 wk of IDA compared with 12 wk. Upregulation of serum Epo concentration and cardiac STAT3 phosphorylation is associated with a beneficial adaptive mechanism of anemia-induced cardiac hypertrophy, and later decreased levels of these molecules may be critical for the transition from adaptive cardiac hypertrophy to cardiac dysfunction in long-term anemia. Understanding the mechanism of cardiac maladaptation to anemia may lead to a new strategy for treatment of chronic heart failure with anemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136608     DOI: 10.1152/ajpheart.00463.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  42 in total

1.  The role of iron, omega-3 Fatty acids, and vitamins in heart failure.

Authors:  Donald S Silverberg; Doron Schwartz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  Subclinical left ventricular systolic impairment in steady state young adult patients with sickle-cell anemia.

Authors:  Nadjib Hammoudi; Dimitri Arangalage; Morad Djebbar; Katia Stankovic Stojanovic; Magali Charbonnier; Richard Isnard; Robert Girot; Pierre-Louis Michel; François Lionnet
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-22       Impact factor: 2.357

3.  Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients.

Authors:  Yao-Peng Hsieh; Ching-Hui Huang; Chia-Ying Lee; Hung-Lin Chen; Ching-Yuang Lin; Chia-Chu Chang
Journal:  World J Nephrol       Date:  2013-05-06

4.  Responses of HSC70 expression in diencephalon to iron deficiency anemia in rats.

Authors:  Fuminori Kawano; Yoshihiko Oke; Sachiko Nomura; Ryo Fujita; Takashi Ohira; Naoya Nakai; Yoshinobu Ohira
Journal:  J Physiol Sci       Date:  2011-08-03       Impact factor: 2.781

5.  Reply to 'Iron restriction in renovascular hypertension'.

Authors:  Yoshiro Naito; Makiko Oboshi; Tohru Masuyama
Journal:  Hypertens Res       Date:  2017-03-02       Impact factor: 3.872

6.  Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents.

Authors:  Terumasa Hayashi; Tomonori Kimura; Keiko Yasuda; Yoshitsugu Obi; Koichi Sasaki; Kenichiro Iio; Kenro Miyasato; Taro Kamimura; Harumi Kitamura; Yoshiharu Tsubakihara; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2012-10-26       Impact factor: 2.801

Review 7.  Intravenous iron in heart failure: beyond targeting anemia.

Authors:  Donald S Silverberg; Adrian Iaina; Doron Schwartz; Dov Wexler
Journal:  Curr Heart Fail Rep       Date:  2011-03

8.  Relation of Red Cell Distribution Width to Left Ventricular End-Diastolic Pressure and Mortality in Patients With and Without Heart Failure.

Authors:  Vichai Senthong; Timothy Hudec; Sarah Neale; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2017-02-10       Impact factor: 2.778

Review 9.  The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome.

Authors:  Donald S Silverberg
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

10.  Left ventricular stiffness in paediatric patients with end-stage kidney disease.

Authors:  Ann Wing-Man Choi; Nai-Chung Fong; Vivian Wing-Yi Li; Tsz-Wai Ho; Eugene Yu-Hin Chan; Alison Lap-Tak Ma; Yiu-Fai Cheung
Journal:  Pediatr Nephrol       Date:  2020-02-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.